Technology News and Research

RSS

SGC, Life Technologies to generate first-ever master set of epigenetic recombinant antibodies

Life Technologies Corporation today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research.

20 Jul 2012

New blood sugar monitor: An interview with Sherita Hill Golden

Type 1 diabetes is a disorder in which the body makes proteins (antibodies) against the cells in the pancreas that produce insulin, destroying those cells. As a result, individuals are unable to secrete insulin to normalize blood sugar and hyperglycemia results.

20 Jul 2012

Study demonstrates how nerve stimulation paired with specific experiences can reorganize the brain

UT Dallas researchers recently demonstrated how nerve stimulation paired with specific experiences, such as movements or sounds, can reorganize the brain. This technology could lead to new treatments for stroke, tinnitus, autism and other disorders.

20 Jul 2012

Nottingham scientists win £1.2M grant for research into engineering of nanomaterials

Pioneering scientists at The University of Nottingham have won a £1.2 million grant for research into the engineering of nanomaterials that could transform the global healthcare industry.

20 Jul 2012

Single-step method can rapidly detect pathogens and chemical contaminants

Using nanoscale materials, researchers at the University of Georgia have developed a single-step method to rapidly and accurately detect viruses, bacteria and chemical contaminants.

20 Jul 2012

TLC announces first Laser Cataract Surgeries to be performed in Canada

TLC Laser Eye Centers is excited to announce the first Laser Cataract Surgeries to be performed in Canada, using an approved femtosecond laser, will take place at TLC's Mississauga center on July 24, 2012.

20 Jul 2012

Viral Genetics initiates Phase 1 trial of MDT compounds for ovarian cancer

The first patient has now been enrolled into the Phase 1 clinical trial sponsored by Viral Genetics' and supported by a donation from Scott and White Foundation. The trial will study Metabolic Disruption Technology (MDT) compounds in combination with an existing cancer therapy to treat drug-resistant ovarian cancer.

20 Jul 2012

WorldOne announces acquisition of Sermo

WorldOne, the global leader in healthcare insights and intelligence, today announced that it has acquired Sermo, the largest online community of U.S. physicians.

20 Jul 2012

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem’s live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem’s strategy, and this research is part of the work towards that goal.

19 Jul 2012

Ellman International acquires Sandstone Medical Technologies

Ellman International, Inc., a global leader in advanced radiofrequency (RF) technology for precision surgical and aesthetic procedures today announced that it has acquired the assets of Sandstone Medical Technologies, LLC., a recognized leader in the aesthetic laser and IPL technology field.

19 Jul 2012

Primcogent Solutions introduces low level laser therapy for onychomycosis

Primcogent Solutions - supplier of the revolutionary ZERONA non-invasive body contouring technology in North America and Western Europe - has announced the launch of Lunula Laser, a clinically proven, low level laser therapy for onychomycosis, for distribution exclusively in Europe.

19 Jul 2012

NeoGenomics second quarter 2012 revenue increases 49% to $15.6 million

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the second quarter 2012.

19 Jul 2012

Green plants in city streets can effectively reduce levels of air pollutants

Trees, bushes and other greenery growing in the concrete-and-glass canyons of cities can reduce levels of two of the most worrisome air pollutants by eight times more than previously believed, a new study has found. A report on the research appears in the ACS journal Environmental Science & Technology.

19 Jul 2012

Pioneering technique that uses thermal imaging can help fight obesity

Scientists at The University of Nottingham believe they've found a way of fighting obesity — with a pioneering technique which uses thermal imaging. This heat-seeking technology is being used to trace our reserves of brown fat — the body's 'good fat' — which plays a key role in how quickly our body can burn calories as energy.

19 Jul 2012

U.S. News names Dana-Farber/ BWH Cancer Center among 2012 America's Best Hospitals

U.S. News & World Report's Best Hospitals guide has ranked Dana-Farber/Brigham and Women's Cancer Center the top cancer center in New England and fifth overall in the country.

19 Jul 2012

Champions Oncology operating revenues increase to $7.1M for the year ended April 30, 2012

Champions Oncology, Inc., formerly Champions Biotechnology, Inc., engages in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the year ended April 30, 2012.

19 Jul 2012

UCSF Medical Center acquires BSD-2000 Hyperthermia System

BSD Medical Corporation announced today that the prestigious University of California San Francisco Medical Center (UCSF Medical Center) has purchased a BSD-2000 Hyperthermia System (BSD-2000).

19 Jul 2012

CSIRO to produce antibodies for development of new vaccines against rotavirus

CSIRO has been contracted by PATH (Program for Appropriate Technology in Health) to produce antibodies on a large scale that will aid the development of new, safe, affordable and effective vaccines against rotavirus, a major cause of severe and fatal diarrhoea in young children worldwide.

18 Jul 2012

Cigna, PAMF launch collaborative accountable care initiative

Cigna and the Palo Alto Medical Foundation (PAMF), a not-for-profit health care organization that is a pioneer in the multispecialty group practice of medicine, have launched a collaborative accountable care initiative to expand patient access to health care, improve care coordination, and achieve the "triple aim" of improved health outcomes (quality), lower total medical costs and increased patient satisfaction.

18 Jul 2012

PPAHS releases safety checklist that targets Patient-Controlled Analgesia

The Physician-Patient Alliance for Health & Safety (PPAHS), an advocacy group devoted to improving patient health and safety, today announced the release of a concise checklist that reminds caregivers of the essential steps needed to be taken to initiate Patient-Controlled Analgesia (PCA) with a patient and to continue to assess that patient's use of PCA.

18 Jul 2012